Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)

The summary for the Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01): This Funding Opportunity Announcement (FOA) encourages innovative multidisciplinary research projects that will advance our mechanistic understanding of microflora influences on Gastro-Intestinal (GI) carcinogenesis. Recent advances in our knowledge of GI microflora composition and function have generated a flood of new information, technologies, and capabilities that may for the first time allow mechanistic investigations of very complex, networked host/microbiome interactions on a systems wide scale.This FOA encourages investigators to ingrate this new information into hypothesis-driven studies that can define and validate molecular mechanisms that determine microbe-induced carcinogenic outcomes.Applicants may integrate information from existing large data sets, including metagenomic data sets,or may also propose to generate appropriate new data sets, including but not limited to analysis of host and microbial genomes, proteomes, metabalomes, post-translational modifications, secreted signals, and protein-protein interaction data. An additional goal of this program is to encourage collaborative efforts between scientists currently engaged in GI cancer research with those in scientific disciplines that may not otherwise apply their expertise to study cancer etiology and prevention. Investigators particularly from the disciplines of microbiology, microbial ecology, molecular biology, immunology, nutrition sciences, bioinformatics, and computational sciences are encouraged to apply. A value added from stimulating integrated, multidisciplinary experimental approaches may include the discovery of emergent properties of the GI ecosystem that could not be elucidated using either descriptive bioinformatics or molecular studies alone.
Federal Grant Title: Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-14-242
Type of Funding: Grant
CFDA Numbers: 93.273, 93.393, 93.396
CFDA Descriptions: Alcohol Research Programs; Cancer Cause and Prevention Research; Cancer Biology Research
Current Application Deadline: Mar 3, 2017
Original Application Deadline: Mar 3, 2017
Posted Date: Jun 3, 2014
Creation Date: Jun 3, 2014
Archive Date: Apr 3, 2017
Total Program Funding:
Maximum Federal Grant Award: none
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
State governments
Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
City or township governments
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-14-242.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...
Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinica...
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clin...
Mechanisms of Alcoholic Pancreatitis
Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com